Clinical Trial Update: Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of bumetanide in Parkinson's disease is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BUMETANIDE (bumetanide)

Snippet

Sponsor: B&A Therapeutics | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN